Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014

Wolff, 2013, Recommendations for human epidermal growth factor receptor 2 testing in breast cancer : American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update, J Clin Oncol, 31, 3997, 10.1200/JCO.2013.50.9984 Hammond, 2010, American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer, J Clin Oncol, 28, 2784, 10.1200/JCO.2009.25.6529 Wolff, 2007, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, 25, 118, 10.1200/JCO.2006.09.2775 Engel, 2011, Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue, Arch Pathol Lab Med, 135, 537, 10.5858/2010-0702-RAIR.1 Khoury, 2009, Delay to formalin fixation effect on breast biomarkers, Mod Pathol, 22, 1457, 10.1038/modpathol.2009.117 Khoury, 2012, Delay to formalin fixation alters morphology and immunohistochemistry for breast carcinoma, Appl Immunohistochem Mol Morphol, 20, 531, 10.1097/PAI.0b013e318248bf6d Neumeister, 2014, A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue, Lab Invest, 94, 467, 10.1038/labinvest.2014.7 Portier, 2013, Delay to formalin fixation “cold ischemia time”: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry, Mod Pathol, 26, 1, 10.1038/modpathol.2012.123 Yildiz-Aktas, 2012, The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma, Am J Clin Pathol, 137, 691, 10.1309/AJCPQRAG67GJRPMT Bussolati, 2008, Tissue transfer to pathology labs: under vacuum is the safe alternative to formalin, Virchows Arch, 452, 229, 10.1007/s00428-007-0529-x Condelli, 2014, Validation of vacuum-based refrigerated system for biobanking tissue preservation : analysis of cellular morphology, protein stability, and RNA quality, Biopreserv Biobank, 12, 35, 10.1089/bio.2013.0065 Vincent-Salomon, 2003, Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study, Histopathology, 42, 337, 10.1046/j.1365-2559.2003.01598.x Babic, 2010, The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays, Methods, 52, 287, 10.1016/j.ymeth.2010.08.012 Goldstein, 2003, Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma, Am J Clin Pathol, 120, 86, 10.1309/QPHDRB00QXGMUQ9N Ibarra, 2010, Fixation time does not affect expression of HER2/neu: a pilot study, Am J Clin Pathol, 134, 594, 10.1309/AJCPAIJPSN4A9MJI Zustin, 2009, HER-2/neu analysis in breast cancer bone metastases, J Clin Pathol, 62, 542, 10.1136/jcp.2008.059717 Pollard, 1987, Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue, J Histochem Cytochem, 35, 1329, 10.1177/35.11.3309048 Lightfoote, 2010 Jones, 2001, Effects of time and temperature during attachment of sections to microscope slides on immunohistochemical detection of antigens, Biotech Histochem, 76, 55, 10.1080/bih.76.2.55.58 DiVito, 2004, Long-term preservation of antigenicity on tissue microarrays, Lab Invest, 84, 1071, 10.1038/labinvest.3700131 Wester, 2000, Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen, Appl Immunohistochem Mol Morphol, 8, 61, 10.1097/00022744-200003000-00010 Jacobs, 1996, Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer, J Natl Cancer Inst, 88, 1054, 10.1093/jnci/88.15.1054 van den Broek, 2000, Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections, Appl Immunohistochem Mol Morphol, 8, 316, 10.1097/00022744-200012000-00009 Dybdal, 2005, Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab, Breast Cancer Res Treat, 93, 3, 10.1007/s10549-004-6275-8 Elsheikh, 2006, Validation of commonly used immunostains on cell-transferred cytologic specimens, Cancer, 108, 135, 10.1002/cncr.21735 Monaco, 2013, Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast, Diagn Cytopathol, 41, 308, 10.1002/dc.21841 Shabaik, 2011, Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma, Diagn Cytopathol, 39, 328, 10.1002/dc.21389